Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
Zhengye Biotechnology Holding Limited (NASDAQ: ZYBT)
ZYBT Stock Predictions and Ratings
WSX Rating:
SELL
WSX Forecast (1yr):
-3.90%
Analyst Rating:
NOT AVAILABLE
Analyst Forecast (1yr):
NOT AVAILABLE
ZYBT Stock Analysis
ZYBT
PE Ratio:
ZYBT
PEG Ratio:
Not Available
ZYBT
Forward EPS Growth (12 month):
0.00%
ZYBT
PS Ratio:
2.3
ZYBT
PSG Ratio:
Not Available
ZYBT
Forward Revenue Growth (12 month):
0.00%
ZYBT Articles
No data was found